NIMOTOP (nimodipine) is a calcium channel blocker indicated for patients with subarachnoid hemorrhage. It improves neurological outcome by relaxing cerebral smooth muscle vasculature and ...

GTX-104 is a clinical stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aSAH patients to address significant unmet medical needs. The unique ...

Nymalize may help reduce the risk of fatal medication errors associated with nimodipine capsule extraction. Nymalize is indicated for the improvement of neurological outcome by reducing the ...

The oral solution in the prefilled ENFit syringe offers a safer alternative for adult subarachnoid haemorrhage patients.

GTX-104 is a clinical stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aSAH patients to address significant unmet medical needs. The unique ...

12, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that ...

The study outcome measure was the effects of nimodipine and magnesium sulfate on cerebral perfusion pressure. Nine patients were randomly selected to receive nimodipine 60 mg orally every four ...

While past research evidence suggested calcium channel blockers—specifically verapamil (brand name is Verelan) and nimodipine ...

A doctor will usually administer nimodipine (Nymalize), a calcium channel blocker, to help reduce the risk of blood supply disruption to the brain. Surgeons will try to repair the ruptured ...

Nymalize may help reduce the risk of fatal medication errors associated with nimodipine capsule extraction. Nymalize is indicated for the improvement of neurological outcome by reducing the incidence ...

05, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that ...